OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 128 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $151,000 | +7.1% | 71,520 | +151.8% | 0.01% | +40.0% |
| Q2 2015 | $141,000 | -56.1% | 28,401 | -30.8% | 0.01% | -54.5% |
| Q1 2015 | $321,000 | +61.3% | 41,046 | +25.0% | 0.01% | +57.1% |
| Q4 2014 | $199,000 | +8.2% | 32,826 | -24.1% | 0.01% | +16.7% |
| Q3 2014 | $184,000 | +37.3% | 43,229 | +98.7% | 0.01% | +50.0% |
| Q2 2014 | $134,000 | -40.4% | 21,761 | -37.2% | 0.00% | -33.3% |
| Q1 2014 | $225,000 | +64.2% | 34,640 | +42.6% | 0.01% | +50.0% |
| Q4 2013 | $137,000 | -78.8% | 24,297 | -76.9% | 0.00% | -78.9% |
| Q3 2013 | $645,000 | +119.4% | 105,247 | +109.0% | 0.02% | +90.0% |
| Q2 2013 | $294,000 | – | 50,346 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,229,287 | $9,625,000 | 44.28% |
| Foresite Capital Management II, LLC | 4,200,047 | $32,886,000 | 19.48% |
| Scale Management, LLC | 2,884,305 | $22,584,000 | 11.28% |
| Cheyne Capital Management (UK) LLP | 1,484,409 | $11,601,000 | 2.80% |
| Telemetry Investments, L.L.C. | 463,039 | $3,626,000 | 2.00% |
| NEA Management Company, LLC | 3,709,000 | $29,041,000 | 1.31% |
| Rock Springs Capital Management LP | 1,550,000 | $12,137,000 | 1.14% |
| Rhenman & Partners Asset Management AB | 831,800 | $6,513,000 | 1.10% |
| Tamarack Capital Management, LLC | 1,000,000 | $7,830,000 | 1.03% |
| RA Capital Management | 1,186,229 | $9,288,000 | 0.92% |